Literature DB >> 28073327

Nonmotor Symptoms in Parkinson Disease: A Descriptive Review on Social Cognition Ability.

Rosanna Palmeri1, Viviana Lo Buono1, Francesco Corallo1, Maria Foti1, Giuseppe Di Lorenzo1, Placido Bramanti1, Silvia Marino1,2.   

Abstract

Parkinson disease (PD) is a neurodegenerative disorder characterized by motor and nonmotor symptoms. Nonmotor symptoms include cognitive deficits and impairment in emotions recognition ability associated with loss of dopaminergic neurons in the substantia nigra and with alteration in frontostriatal circuits. In this review, we analyzed the studies on social cognition ability in patients with PD. We searched on PubMed and Web of Science databases and screening references of included studied and review articles for additional citations. From initial 260 articles, only 18 met search criteria. A total of 496 patients were compared with 514 health controls, through 16 different tests that assessed some subcomponents of social cognition, such as theory of mind, decision-making, and emotional face recognition. Studies on cognitive function in patients with PD have focused on executive function. Patients with PD showed impairment in social cognition from the earliest stages of disease. This ability seems to not be significantly associated with other cognitive functions.

Entities:  

Keywords:  Parkinson disease; ToM ability; decision-making; executive functions; social cognition

Mesh:

Year:  2017        PMID: 28073327     DOI: 10.1177/0891988716687872

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  14 in total

1.  Assessment of Duodopa® effects on quality of life of patients with advanced Parkinson's disease and their caregivers.

Authors:  Rosella Ciurleo; Francesco Corallo; Lilla Bonanno; Viviana Lo Buono; Giuseppe Di Lorenzo; Roberta Versaci; Cettina Allone; Rosanna Palmeri; Placido Bramanti; Silvia Marino
Journal:  J Neurol       Date:  2018-06-27       Impact factor: 4.849

2.  Early Sociability and Social Memory Impairment in the A53T Mouse Model of Parkinson's Disease Are Ameliorated by Chemogenetic Modulation of Orexin Neuron Activity.

Authors:  Milos Stanojlovic; Jean Pierre Pallais Yllescas; Aarthi Vijayakumar; Catherine Kotz
Journal:  Mol Neurobiol       Date:  2019-06-27       Impact factor: 5.590

3.  Rehabilitation in atypical neurological disease: a case report.

Authors:  Francesco Corallo; Carmela Rifici; Viviana Lo Buono
Journal:  J Int Med Res       Date:  2022-06       Impact factor: 1.573

4.  An unexpected improvement in spatial learning and memory ability in alpha-synuclein A53T transgenic mice.

Authors:  Qi Liu; YuYu Xu; WenPing Wan; ZeGang Ma
Journal:  J Neural Transm (Vienna)       Date:  2017-12-07       Impact factor: 3.575

5.  Dopaminergic Therapy Increases Go Timeouts in the Go/No-Go Task in Patients with Parkinson's Disease.

Authors:  Xue Q Yang; Brian Lauzon; Ken N Seergobin; Penny A MacDonald
Journal:  Front Hum Neurosci       Date:  2018-01-04       Impact factor: 3.169

6.  Investigation of Behavioral Dysfunctions Induced by Monoamine Depletions in a Mouse Model of Parkinson's Disease.

Authors:  Yong Li; Qian Jiao; Xixun Du; Mingxia Bi; Shuaishuai Han; Lingling Jiao; Hong Jiang
Journal:  Front Cell Neurosci       Date:  2018-08-08       Impact factor: 5.505

7.  Social cognition remediation interventions: A systematic mapping review.

Authors:  Patricia Fernández-Sotos; Iosune Torio; Antonio Fernández-Caballero; Elena Navarro; Pascual González; Mónica Dompablo; Roberto Rodriguez-Jimenez
Journal:  PLoS One       Date:  2019-06-26       Impact factor: 3.240

8.  Dementia-Related Functional Disability in Moderate to Advanced Parkinson's Disease: Assessment Using the World Health Organization Disability Assessment Schedule 2.0.

Authors:  Jia-Hung Chen; Chien-Tai Hong; Dean Wu; Wen-Chou Chi; Chia-Feng Yen; Hua-Fang Liao; Lung Chan; Tsan-Hon Liou
Journal:  Int J Environ Res Public Health       Date:  2019-06-24       Impact factor: 3.390

9.  Quantitative assessment of Parkinsonian tremor by using biosensor device.

Authors:  Silvia Marino; Emanuele Cartella; Nicola Donato; Nunzio Muscarà; Chiara Sorbera; Vincenzo Cimino; Simona De Salvo; Katia Micchìa; Giuseppe Silvestri; Alessia Bramanti; Giuseppe Di Lorenzo
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

10.  The effect on deep brain stimulation of subthalamic nucleus and dopaminergic treatment in Parkinson disease.

Authors:  Viviana Lo Buono; Rosanna Palmeri; Giuseppe Stroscio; Francesco Corallo; Giuseppe Di Lorenzo; Chiara Sorbera; Rosella Ciurleo; Vincenzo Cimino; Placido Bramanti; Silvia Marino; Lilla Bonanno
Journal:  Medicine (Baltimore)       Date:  2020-08-07       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.